Tower Research Capital (TRC)’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-3,152
Closed -$150K 5126
2025
Q3
$150K Sell
3,152
-15,217
-83% -$737K ﹤0.01% 1703
2025
Q2
$980K Buy
18,369
+16,727
+1,019% +$760K 0.03% 557
2025
Q1
$66.5K Sell
1,642
-14,546
-90% -$617K ﹤0.01% 2020
2024
Q4
$450K Buy
16,188
+14,329
+771% +$434K 0.01% 1146
2024
Q3
$53.3K Sell
1,859
-13,783
-88% -$359K ﹤0.01% 2687
2024
Q2
$367K Buy
15,642
+14,758
+1,669% +$316K 0.01% 1592
2024
Q1
$22.3K Sell
884
-3,060
-78% -$73.5K ﹤0.01% 2904
2023
Q4
$92.1K Buy
3,944
+2,898
+277% +$57.2K ﹤0.01% 2713
2023
Q3
$52.9K Sell
1,046
-952
-48% -$44.3K ﹤0.01% 2503
2023
Q2
$93.3K Sell
1,998
-1,937
-49% -$88.8K ﹤0.01% 2071
2023
Q1
$150K Buy
3,935
+1,802
+84% +$80.3K ﹤0.01% 1535
2022
Q4
$116K Buy
2,133
+1,102
+107% +$47.2K ﹤0.01% 1715
2022
Q3
$35K Sell
1,031
-7,136
-87% -$109K ﹤0.01% 3464
2022
Q2
$77K Sell
8,167
-14,891
-65% -$155K ﹤0.01% 2493
2022
Q1
$328K Buy
23,058
+21,305
+1,215% +$373K ﹤0.01% 1426
2021
Q4
$37K Sell
1,753
-38
-2% -$843 ﹤0.01% 3013
2021
Q3
$40K Sell
1,791
-961
-35% -$21.8K ﹤0.01% 3123
2021
Q2
$68K Buy
2,752
+1,868
+211% +$52.5K ﹤0.01% 2757
2021
Q1
$26K Sell
884
-2,922
-77% -$88.5K ﹤0.01% 3665
2020
Q4
$98K Buy
3,806
+2,228
+141% +$62K ﹤0.01% 2364
2020
Q3
$49K Buy
1,578
+36
+2% +$1.26K ﹤0.01% 3546
2020
Q2
$38K Buy
1,542
+860
+126% +$19.7K ﹤0.01% 3257
2020
Q1
$14K Sell
682
-2,367
-78% -$50.8K ﹤0.01% 1866
2019
Q4
$68K Buy
+3,049
New +$63.1K 0.01% 1145
2019
Q3
Sell
-1,381
Closed -$26K 4044
2019
Q2
$26K Buy
+1,381
New +$26.2K ﹤0.01% 1992

Other funds holding AKRO